RECOMBINANT PROTEIN MARKET ANALYSIS

Recombinant Protein Market, by Product Type (Antibodies, Antigens, Enzymes, Hormones and Others), by Expression System (Microbes, Plant and Animal), by Application ( Drug Discovery and Development, Research Application, Therapeutic Use, Diagnostics, and Others), by End User (Biotechnology and Pharmaceutical Companies, Academic Research Institutes, Contract Research Organizations and Others), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jan 2023
Code : CMI1516
Pages :270
Formats :
Excel and PDF
Industry : Biotechnology

Market News

Global Recombinant Protein Market: Key Developments

In February 2022, Rockland Immuno chemicals, Inc. (Rockland), a company specialized in life science tools and services, announced that it had completed the acquisition of antibodies-online, a vendor-independent marketplace for antibodies, ELISA kits, and related research reagent. The recombinant protein were used in various kits and reagent thus the acquisition helps to expand recombinant product portfolio.

In June 2021, the Indian government made an investment of Rs. 1,500 crore (US$ 183.9 million) in recombinant protein COVID-19 vaccine, Corbevax, for mass immunization.